Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6571)
All Articles published online
|
Publishing Process of This Article
|
May 28, 2015 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lückhoff HK, Kruger FC, Kotze MJ. Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries. World J Hepatol 2015; 7(9): 1192-1208 [PMID: 26019735 DOI: 10.4254/wjh.v7.i9.1192] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i9/1192.htm |
| Number | Citing Articles |
| 1 |
Pterostilbene Reduces Liver Steatosis and Modifies Hepatic Fatty Acid Profile in Obese Rats. Nutrients 2019; 11(5): 961 doi: 10.3390/nu11050961
|
| 2 |
Teresa Auguet, Gemma Aragonès, Alba Berlanga, Esther Guiu-Jurado, Andreu Martí, Salomé Martínez, Fàtima Sabench, Mercé Hernández, Carmen Aguilar, Joan Sirvent, Daniel del Castillo, Cristóbal Richart. miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2016; 17(10): 1620 doi: 10.3390/ijms17101620
|
| 3 |
K.C. van Son, L.C. te Nijenhuis-Noort, S.C. Boone, D.O. Mook-Kanamori, A.G. Holleboom, P.R. Roos, H.J. Lamb, G. Alblas, M.J. Coenraad, F.R. Rosendaal, R. de Mutsert, M.E. Tushuizen. Prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in a middle-aged population with overweight and normal liver enzymes, and diagnostic accuracy of noninvasive proxies. Medicine 2024; 103(1): e34934 doi: 10.1097/MD.0000000000034934
|
| 4 |
Yu-Jie Zhou, Ji-Na Zheng, Wen-Yue Liu, Luca Miele, Alessandro Vitale, Sven Van Poucke, Tian-Tian Zou, Dan-Hong Fang, Shengrong Shen, Dong-Chu Zhang, Ming-Hua Zheng. The NAFL Risk Score: A simple scoring model to predict 4-y risk for non-alcoholic fatty liver. Clinica Chimica Acta 2017; 468: 17 doi: 10.1016/j.cca.2017.01.021
|
| 5 |
William N. Evans, Ruben J. Acherman, Michael L. Ciccolo, Sergio A. Carrillo, Alvaro Galindo, Abraham Rothman, Gary A. Mayman, Elizabeth A. Adams, Leigh C. Reardon, Brody J. Winn, Noel S. Yumiaco, Lesley Shimuizu, Yoko Inanaga, Rowena J. Deleon, Humberto Restrepo. A composite noninvasive index correlates with liver fibrosis scores in post-Fontan patients: Preliminary findings. Congenital Heart Disease 2018; 13(1): 38 doi: 10.1111/chd.12558
|
| 6 |
Pierre Bedossa, Keyur Patel. Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease. Gastroenterology 2016; 150(8): 1811 doi: 10.1053/j.gastro.2016.03.008
|
| 7 |
Stephen A. Harrison, Andrea Dennis, Martine M. Fiore, Matt D. Kelly, Catherine J. Kelly, Angelo H. Paredes, Jennifer M. Whitehead, Stefan Neubauer, Peter G. Traber, Rajarshi Banerjee, Jee-Fu Huang. Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial. PLOS ONE 2018; 13(9): e0203054 doi: 10.1371/journal.pone.0203054
|
| 8 |
Daniel Rico, Ana Belén Martin-Diana, Arrate Lasa, Leixuri Aguirre, Iñaki Milton-Laskibar, Daniel Antonio De Luis, Jonatan Miranda. Effect of Wakame and Carob Pod Snacks on Non-Alcoholic Fatty Liver Disease. Nutrients 2019; 11(1): 86 doi: 10.3390/nu11010086
|